W. M. Sikov - Concepedia

Author

W. M. Sikov

Rhode Island Hospital

Also Known As

Shepherd, J.H, W M Sikov, W Sikov, W. M. Sikov, W. Sikov, W.M. Sikov, WM Sikov

Publications

348

Citations

H-Index

Concepts

All Affiliations

Rhode Island Hospital Dana-Farber Cancer Institute City of Hope City Of Hope National Medical Center

About

W. M. Sikov is an author at Rhode Island Hospital specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	268
2	Health Sciences	2	2	128
3	Obstetrics	2	2	128
4	Orthopaedics	2	2	128
5	Clinical Nutrition	1	1	100

W. M. Sikov

Publications

331

Citations

H-Index

Page 1

	Year	Citations
Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: Final results from CALGB trial 79809 Charles L. Shapiro, Susan Halabi, Vera Hárs, European Journal of Cancer Calgb Trial 79809Bone DiseaseZoledronic AcidBone HealthMedicine	2011	100
Abstract S2-05: Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast cancer: Outcomes from CALGB 40603 (Alliance) W. M. Sikov, DA Berry, CM Perou, Cancer Research Breast OncologyCancer EpidemiologyOverall SurvivalPcr RateMedicine	2016	86
Abstract S5-01: Impact of the addition of carboplatin (Cb) and/or bevacizumab (B) to neoadjuvant weekly paclitaxel (P) followed by dose-dense AC on pathologic complete response (pCR) rates in triple-negative breast cancer (TNBC): CALGB 40603 (Alliance) W. M. Sikov, DA Berry, CM Perou, Cancer Research Breast OncologyPathologic Complete ResponsePathologyPharmacotherapyTumor Biology	2013	54
Weekly high-dose paclitaxel in metastatic and locally advanced breast cancer: a preliminary report. Wallace Akerley, W. M. Sikov, F J Cummings, PubMed	1997	34
Weekly paclitaxel in patients with advanced lung cancer: preliminary data from a phase II trial. Wallace Akerley, Hak Choy, Howard Safran, PubMed	1997	29
Effect of zoledronic acid (ZA) on bone mineral density (BMD) in premenopausal women who develop ovarian failure (OF) due to adjuvant chemotherapy (AdC): First results from CALGB trial 7980 Charles L. Shapiro, Susan Halabi, G W Gibson, Journal of Clinical Oncology GynecologyPharmacotherapyOrthopaedic SurgeryOsteoporosisGynecology Oncology	2008	28

Page 1